New COVID-19 Research: Universities and Research Organizations Highly Active in Vaccine Patenting During Pandemic's Early Days; China, U.S.-based Applicants Lead in Vaccine and Therapeutics Innovation (PR/2022/887)
Universities and research organizations filed nearly as many patent applications as corporations for COVID-19 vaccines during the early months of the global pandemic, with China and U.S.-based innovators most actively patenting new anti-COVID19 vaccine and therapeutic technologies, according to a WIPO report on pandemic-era innovation trends released today.